Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-19T15:46:43.820Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of cascade reporting of antimicrobial susceptibility on fluoroquinolone and meropenem consumption at a Veterans’ Affairs medical center

Published online by Cambridge University Press:  06 April 2021

Nicole C. Vissichelli Open the ORCID record for Nicole C. Vissichelli [Opens in a new window] ,
Christine M. Orndahl ,
Jane A. Cecil ,
Emily M. Hill ,
Matthew M. Hitchcock ,
Roy T. Sabo ,
Michael P. Stevens ,
Dan Tassone ,
Leroy B. Vaughan  and
J. Daniel Markley
Nicole C. Vissichelli*
Affiliation:
Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, Virginia Department of Infectious Diseases, Hunter Holmes McGuire Veteran’s Affairs Medical Center, Richmond, Virginia
Christine M. Orndahl
Affiliation:
Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia
Jane A. Cecil
Affiliation:
Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, Virginia Department of Infectious Diseases, Hunter Holmes McGuire Veteran’s Affairs Medical Center, Richmond, Virginia
Emily M. Hill
Affiliation:
Department of Pathology, Hunter Holmes McGuire Veteran’s Affairs Medical Center, Richmond, Virginia
Matthew M. Hitchcock
Affiliation:
Department of Infectious Diseases, Hunter Holmes McGuire Veteran’s Affairs Medical Center, Richmond, Virginia
Roy T. Sabo
Affiliation:
Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia
Michael P. Stevens
Affiliation:
Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, Virginia
Dan Tassone
Affiliation:
Department of Infectious Diseases, Hunter Holmes McGuire Veteran’s Affairs Medical Center, Richmond, Virginia
Leroy B. Vaughan
Affiliation:
Department of Infectious Diseases, Hunter Holmes McGuire Veteran’s Affairs Medical Center, Richmond, Virginia
J. Daniel Markley
Affiliation:
Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, Virginia Department of Infectious Diseases, Hunter Holmes McGuire Veteran’s Affairs Medical Center, Richmond, Virginia
*
Author for correspondence: Nicole Vissichelli, E-mail: Nicole.Vissichelli@vcuhealth.org
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine whether cascade reporting is associated with a change in meropenem and fluoroquinolone consumption.

Design:

A quasi-experimental study was conducted using an interrupted time series to compare antimicrobial consumption before and after the implementation of cascade reporting.

Setting:

A 399-bed, tertiary-care, Veterans’ Affairs medical center.

Participants:

Antimicrobial consumption data across 8 inpatient units were extracted from the Center for Disease Control and Prevention (CDC) National Health Safety Network (NHSN) antimicrobial use (AU) module from April 2017 through March 2019, reported as antimicrobial days of therapy (DOT) per 1,000 days present (DP).

Intervention:

Cascade reporting is a strategy of reporting antimicrobial susceptibility test results in which secondary agents are only reported if an organism is resistant to primary, narrow-spectrum agents. A multidisciplinary team developed cascade reporting algorithms for gram-negative bacteria based on local antibiogram and infectious diseases practice guidelines, aimed at restricting the use of fluoroquinolones and carbapenems. The algorithms were implemented in March 2018.

Results:

Following the implementation of cascade reporting, mean monthly meropenem (P =.005) and piperacillin/tazobactam (P = .002) consumption decreased and cefepime consumption increased (P < .001). Ciprofloxacin consumption decreased by 2.16 DOT per 1,000 DP per month (SE, 0.25; P < .001). Clostridioides difficile rates did not significantly change.

Conclusion:

Ciprofloxacin consumption significantly decreased after the implementation of cascade reporting. Mean meropenem consumption decreased after cascade reporting was implemented, but we observed no significant change in the slope of consumption. cascade reporting may be a useful strategy to optimize antimicrobial prescribing.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 43 , Issue 2 , February 2022 , pp. 199 - 204
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION. These data were accepted as an abstract poster presentation for ID Week 2020 on October 21–25, 2020, at this virtual conference online.

References

Antibiotic resistance threats in the United States. Centers for Disease Control website. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. Published 2019. Accessed March 4, 2021.Google Scholar
Richter, SE, Miller, L, Needleman, J, et al. Risk factors for development of carbapenem resistance among gram-negative rods. Open Forum Infect Dis 2019. doi: 10.1093/ofid/ofz027.CrossRefGoogle ScholarPubMed
Seddon, MM, Bookstaver, PB, Justo, JA, et al. Role of early de-escalation of antimicrobial therapy on risk of Clostridioides difficile infection following Enterobacteriaceae bloodstream infections. Clin Infect Dis 2019;69:414–420.10.1093/cid/ciy863CrossRefGoogle ScholarPubMed
Pollack, LA, Srinivasan, A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis 2014;59 suppl 3:S97–S100.10.1093/cid/ciu542CrossRefGoogle ScholarPubMed
Werner, NL, Hecker, MT, Sethi, AK, Donskey, CJ. Unnecessary use of fluoroquinolone antibiotics in hospitalized patients. BMC Infect Dis 2011;11:187.10.1186/1471-2334-11-187CrossRefGoogle ScholarPubMed
Kabbani, S, Hersh, AL, Shapiro, DJ, Fleming-Dutra, KE, Pavia, AT, Hicks, LA. Opportunities to improve fluoroquinolone prescribing in the United States for adult ambulatory care visits. Clin Infect Dis 2018;67:134–136.10.1093/cid/ciy035CrossRefGoogle ScholarPubMed
Altunsoy, A, Aypak, C, Azap, A, Ergönül, Ö, Balık, İ. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int J Med Sci 2011;8:339–344.10.7150/ijms.8.339CrossRefGoogle ScholarPubMed
Mladenovic-Antic, S, Kocic, B, Velickovic-Radovanovic, R, et al. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study. J Clin Pharm Ther 2016;41:532–537.10.1111/jcpt.12432CrossRefGoogle Scholar
Zou, YM, Ma, Y, Liu, JH, et al. Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009–2013). Eur J Clin Microbiol Infect Dis 2015;34:795–803.10.1007/s10096-014-2293-6CrossRefGoogle Scholar
Patel, N, Harrington, S, Dihmess, A, et al. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J Antimicrob Chemother 2011;66:1600–1608.10.1093/jac/dkr156CrossRefGoogle ScholarPubMed
Barlam, TF, Cosgrove, SE, Abbo, LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62(10):e51–e77.10.1093/cid/ciw118CrossRefGoogle Scholar
Langford, BJ, Leung, E, Haj, R, et al. Nudging in MicroBiology Laboratory Evaluation (NIMBLE): a scoping review. Infect Control Hosp Epidemiol 2019;40:1400–1406.10.1017/ice.2019.293CrossRefGoogle Scholar
Weinstein, MP. Performance Standards for Antimicrobial Susceptibility Testing. Annapolis, MD: Clinical and Laboratory Standards Institute; 2019.Google Scholar
McNulty, CAM, Lasseter, GM, Charlett, A, et al. Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections? J Antimicrob Chemother 2011;66:1396–1404.10.1093/jac/dkr088CrossRefGoogle ScholarPubMed
Tan, TY, McNulty, C, Charlett, A, Nessa, N, Kelly, C, Beswick, T. Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice. J Antimicrob Chemother 2003;51:379–384.10.1093/jac/dkg032CrossRefGoogle ScholarPubMed
Pulcini, C, Tebano, G, Mutters, NT, et al. Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey on behalf of the EUCIC-ESGAP-EUCAST Selective Reporting Working Group 1. Int J Antimicrob Agents 2017;49:162–166.10.1016/j.ijantimicag.2016.11.014CrossRefGoogle Scholar
Coupat, C, Pradier, C, Degand, N, Hofliger, P, Pulcini, C. Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study. Eur J Clin Microbiol Infect Dis 2013;32:627–636.10.1007/s10096-012-1786-4CrossRefGoogle ScholarPubMed
Bourdellon, L, Thilly, N, Fougnot, S, Pulcini, C, Henard, S. Impact of selective reporting of antibiotic susceptibility test results on the appropriateness of antibiotics chosen by French general practitioners in urinary tract infections: a randomised controlled case-vignette study. Int J Antmicrob Agents 2017;50:258–262.10.1016/j.ijantimicag.2017.01.040CrossRefGoogle ScholarPubMed
Liao, S, Rhodes, J, Jandarov, R, DeVore, Z, Sopirala, MM. Out of sight-out of mind: impact of cascade reporting on antimicrobial usage. Open Forum Infect Dis 2020. doi: 10.1093/ofid/ofaa002.Google ScholarPubMed
Johnson, LS, Patel, D, King, EA, Maslow, JN. Impact of microbiology cascade reporting on antibiotic de-escalation in cefazolin-susceptible gram-negative bacteremia. Eur J Clin Microbiol Infect Dis 2016;35:1151–1157.10.1007/s10096-016-2645-5CrossRefGoogle ScholarPubMed
Langford, BJ, Seah, J, Chan, A, Downing, M, Johnstone, J, Matukas, LM. Antimicrobial stewardship in the microbiology laboratory: impact of selective susceptibility reporting on ciprofloxacin utilization and susceptibility of gram-negative isolates to ciprofloxacin in a hospital setting. J Clin Microbiol 2016;54:2343–2347.10.1128/JCM.00950-16CrossRefGoogle Scholar
Dallas, A, Van Driel, M, Van De Mortel, T, Magin, P. Antibiotic prescribing for the future: exploring the attitudes of trainees in general practice. Br J Gen Pract 2014;64(626):e561–e567.10.3399/bjgp14X681373CrossRefGoogle ScholarPubMed
van Santen, KL, Edwards, JR, Webb, AK, et al. The standardized antimicrobial administration ratio: a new metric for measuring and comparing antibiotic use. Clin Infect Dis 2018;67:179–185.10.1093/cid/ciy075CrossRefGoogle ScholarPubMed
Musgrove, MA, Kenney, RM, Kendall, RE, et al. Microbiology comment nudge improves pneumonia prescribing. Open Forum Infect Dis 2018;5(7):ofy162.10.1093/ofid/ofy162CrossRefGoogle ScholarPubMed
Peterson, LR. Squeezing the antibiotic balloon: The impact of antimicrobial classes on emerging resistance. Clin Microbiol Infect Suppl 2005;11(5):4–16.10.1111/j.1469-0691.2005.01238.xCrossRefGoogle ScholarPubMed